Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Even a highly purified peptide can produce inconsistent experimental results if it is improperly reconstituted, contaminated during handling, or stored outside recommended conditions
Pak J Bot
A structure-based designed inhibitor of Bcr-Abl-T315I, ponatinib, was developed and used in the clinical trial
298(6):R1475R1484., Basic mechanism
Erovic et al
Guaranteeing consistency across experimental replicates
US$ 24.16
US$ 25.44
US$ 29.15
US$ 28.09
US$ 26.93
US$ 24.14
US$ 25.91
US$ 29.16
US$ 27.98
